Antibody glycosylation in COVID-19

被引:0
作者
Tamas Pongracz
Gestur Vidarsson
Manfred Wuhrer
机构
[1] Leiden University Medical Center,Center for Proteomics and Metabolomics
[2] University of Amsterdam,Department of Experimental Immunohematology, Sanquin Research, and Landsteiner Laboratory, UMC
来源
Glycoconjugate Journal | 2022年 / 39卷
关键词
IgG glycosylation; Antibody glycosylation; SARS-CoV-2; COVID-19; Glycomics, biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:335 / 344
页数:9
相关论文
共 359 条
  • [1] Vidarsson G(2014)IgG subclasses and allotypes: from structure to effector functions Front. Immunol. 5 520-61
  • [2] Dekkers G(2017)Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities Front. Immunol. 8 877-79
  • [3] Rispens T(2018)Beyond binding: antibody effector functions in infectious diseases Nat. Rev. Immunol. 18 46-1861
  • [4] Dekkers G(2018)Immunoglobulin G glycosylation in aging and diseases Cell. Immunol. 333 65-969
  • [5] Treffers L(2016)Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood J. Proteome Res. 15 1853-372
  • [6] Plomp R(2010)Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans Glycobiology 20 959-253
  • [7] Bentlage AEH(2017)The Immunoregulatory Roles of Antibody Glycosylation Trends Immunol. 38 358-110
  • [8] de Boer M(2020)Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases Glycobiology 30 241-213
  • [9] Koeleman CAM(2018)Antibody glycosylation in inflammation, disease and vaccination Semin. Immunol. 39 102-153
  • [10] Lissenberg-Thunnissen SN(2020)The history of IgG glycosylation and where we are now Glycobiology 30 202-30